Mobile Health Technology for Palliative Care Patients

NCT03038841 | Unknown

• 1 other identifier: PC 16/16
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

To test the potential and acceptance of wireless activity tracking in palliative care patients leaving hospital care. Explorative study, collaboration project of the Clinic of Radiation-Oncology, University Hospital Zurich and the Wearable Computing Laboratory, Swiss Federal Institut of Technology. Patients receive a tracking bracelet and a smart phone in order to gather objective physical activity parameters as step count, sleep duration, heart rate, social activity patterns (e.g. making calls) as well as subjective ratings of pain and distress. Quality of life (QoL) will be captured by paper questionnaire. Correlations between patients' physical activity patterns and the pain and distress level assessed from electronic scales as well as QoL-questionnaire will be performed. Acceptance will be evaluated by quantitative questionnaires and interviews. The proposed study is meant to be preparatory work for an intervention study to test the effect of wireless monitoring of palliative care patients on fostering early interventions for symptom relief and support of QoL.

Conditions

Metastatic Cancer; Mobile Health; Chronic Disease

Outcome Measures

Primary Outcomes (1)

• Feasibility (time of complete data transfer in weeks)

  time of complete data transfer in weeks

  12 weeks

Interventions

Mobile Health DEVICE

Patients discharged from hospital will be equipped with a tracking bracelet and a smart phone

Eligibility Criteria

• Age: 18 Years - 105 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients hospitalized at one of the wards of the Clinic of Radiation-Oncology University Hospital Zurich, including a ward of specialized Palliative Care

You may qualify if:

• established diagnosis of metastatic cancer or other severe illness with limited life-expectancy (physicians guess \<12 months, \> 8 weeks)
• Karnofsky Index ≥50%
• ECOG≤ 2
• aged \> 18 years
• passed a short handling test with devices (tracking bracelet, smart phone)

You may not qualify if:

• relevant cognitive impairment
• insufficient knowledge of German language.

Sponsors & Collaborators

• University of Zurich: lead
• Swiss Federal Institute of Technology: collaborator
• Swiss Academy of Medical Sciences (SAMS): collaborator

Study Sites (1)

Clinic of Radiation-Oncology University Hospital Zurich

Zurich, Canton of Zurich, 8091, Switzerland

RECRUITING

MeSH Terms

Conditions

Neoplasm Metastasis; Chronic Disease

Condition Hierarchy (Ancestors)

Neoplastic Processes; Neoplasms; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Disease Attributes

Study Officials

• Matthias Guckenberger, Prof

  Clinic of Radiation-Oncology USZ

  STUDY CHAIR

• Gerhard Tröster, Prof

  ETH Zürich

  STUDY CHAIR

• Gudrun Theile, MD

  Clinic of Radiation-Oncology USZ

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Gudrun Theile, MD

CONTACT

+41 44 255 5495; gudrun.theile@usz.ch

Matea Pavic, MD

CONTACT

+41 44 255 3015; matea.pavic@usz.ch

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 12 Weeks
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 25, 2017
• First Posted: February 1, 2017
• Study Start: February 1, 2017
• Primary Completion: May 31, 2018
• Study Completion: May 31, 2018
• Last Updated: June 21, 2017

Record last verified: 2017-01

Data Sharing

• IPD Sharing: Will not share

Locations

CH (1)